Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial.

Cella, David; Grünwald, Viktor; Nathan, Paul; Doan, Justin; Dastani, Homa; Taylor, Fiona; Bennett, Bryan; DeRosa, Michael; Berry, Scott; Broglio, Kristine; Berghorn, Elmer; Motzer, Robert J.
Lancet Oncol; 17(7): 994-1003, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27283863